|
LTC2785706I2
(en)
|
|
SUBSTITUTED 4-PHENYL-PYRIDINES FOR THE TREATMENT OF NK-RECEPTOR-RELATED DISEASES
|
|
HRP20181558T1
(en)
|
|
Fusion proteins for treating metabolic disorders
|
|
DK2919796T3
(en)
|
|
USE OF AKKERMANSIA FOR THE TREATMENT OF METABLE DISEASES
|
|
DK3811943T3
(en)
|
|
Compound for use in the treatment of eye disorders
|
|
DK2895156T3
(en)
|
|
Method for the preparation of therapeutic nanoparticles
|
|
DK2734126T3
(en)
|
|
MEDICAL DEVICES WITH REMOVABLE THREADABLE BUYERS
|
|
DK2938740T3
(en)
|
|
CHIMARY FGF19 PEPTIDES FOR USE IN THE TREATMENT OF BALIDIC ACID DISORDERS
|
|
HK1216159A1
(en)
|
|
Therapeutic fusion protein
|
|
DK2747763T3
(en)
|
|
(BACTERIO-) CHLOROPHYLL PHOTOSENSIBILIZERS FOR THE TREATMENT OF EYE DISEASES AND DISORDERS
|
|
IL235058A0
(en)
|
|
Pharmaceutical combinations for the treatment of metabolic disorders
|
|
DK2783256T3
(en)
|
|
THERAPEUTIC GLASSES
|
|
CO6880064A2
(en)
|
|
Therapeutic methods
|
|
DK2961426T3
(en)
|
|
TREATMENT OF DISEASES IN THE CENTRAL NERVOUS SYSTEM BY INTRANASAL ADMINISTRATION OF IMMUNOGLOBULIN G
|
|
DK3351554T3
(en)
|
|
GLUTEN-RELATED DISORDERS
|
|
ITRM20120530A1
(en)
|
|
COMPOUNDS FOR USE IN THE TREATMENT OF PARASITIC DISEASES
|
|
IL243637A0
(en)
|
|
Ppar-sparing compounds for the treatment of metabolic diseases
|
|
TH148777B
(en)
|
|
Protein fusion for the treatment of metabolic disorders
|
|
GB201207363D0
(en)
|
|
Compounds for the treatment of metabolic disorders
|
|
GB201207359D0
(en)
|
|
Compounds for the treatment of metabolic disorders
|
|
ES1075603Y
(en)
|
|
THERAPEUTIC OBJECT
|
|
FI9763U1
(en)
|
|
funeral Kista
|